Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.634.24-9.38-22.7066.63

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is -5.63 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70
Mar202166.63

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7
Negative
Mar2021 66.63 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,941.4 Cr 4.5% 5.1% -9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

4.5%

5.1%

-9.9%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses